— Know what they know.
Not Investment Advice

TRVN OTC

Trevena, Inc.
1W: +7.1% 1M: +1100.0% 3M: +500.0% YTD: +0.0% 1Y: +0.0% 3Y: -99.9% 5Y: -100.0%
$0.01
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 53 · $10365 mcap · 859072 float · 0.019% daily turnover · Short 32% of daily vol

Income Trends

Revenue
$3M +847.6% ▲
5Y CAGR: -11.4%
Gross Profit
$1M +142.3% ▲
5Y CAGR: -24.0%
Operating Income
-$35M +37.4% ▲
Net Income
-$40M +24.9% ▲
EPS (Diluted)
$-3.16 +58.4% ▲
EBITDA
-$35M +32.8% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2019FY2020FY2021FY2022FY2023
Revenue$31K$3M$567K-$418K$3M
YoY Growth-99.5%+9800.0%-81.5%-173.7%+847.6%
Cost of Revenue$108K$182K$954K$3M$2M
Gross Profit-$77K$3M-$387K-$3M$1M
Gross Margin-248.4%94.1%-68.3%822.0%46.6%
R&D Expenses$13M$13M$13M$18M$16M
SG&A Expenses$13M$19M$38M$35M$20M
Operating Expenses$27M$32M$52M$53M$37M
Operating Income-$27M-$29M-$52M-$56M-$35M
Operating Margin-85741.9%-960.7%-9157.8%13486.8%-1129.2%
Interest Expense$931K$29K$1K$1M$0
Income Before Tax-$25M-$29M-$52M-$54M-$40M
Tax Expense$0$300K$0$0$318K
Net Income-$25M-$29M-$52M-$54M-$40M
Net Margin-80229.0%-957.0%-9098.4%12839.1%-1289.2%
EPS (Diluted)$-7.65$-5.75$-7.90$-7.59$-3.16
EBITDA-$26M-$29M-$51M-$52M-$35M
Shares Outstanding4M5M7M7M14M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms